| Symbol | VFYLF |
|---|---|
| Name | VITRAFY LIFE SCIENCES LTD. |
| Sector | UNDEFINED |
| Region | Oceania |
| Industry | - |
| Address | 3000 Australia VIC Suite 2, Level 11, 385 Bourke Street |
| Telephone | +61 3 4331 9974 |
| Fax | — |
| — | |
| Website | https://vitrafy.com/ |
| Incorporation | AU |
| Incorporated On | 2017 |
| Employees | — |
| Fiscal Year | 6/30 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | — |
| Audit Status | AUDITED |
| Reporting Status | International Reporting: ASX - Australian Securities Exchange |
| CIK | — |
| Description | Vitrafy Life Sciences Limited engages in the research, development, and commercialization of cryopreservation solutions in Australia. The company offers smart devices, such as smart cryopreservation, smart thawing, and smart packaging devices. It also provides a software platform, which controls, trace, tracks, and monitors quality of cryopreserved biomaterials under the LifeChain brand. The companys cryopreservation technology is used various applications, such as blood platelets, cell and gene therapies, and aquaculture and bovine breeding programs. Additional info from OTC: |
No news found.